发明名称 |
HEMOGLOBIN RECEPTOR AS NOVEL VACCINE FOR LEISHMANIASIS |
摘要 |
The present invention in general relates Hemoglobin receptor or its part as a novel vaccine candidate against Leishmaniasis. Specifically, the present invention envisages HbR DNA for eliciting immune response in a mammal against Leishmaniasis. Additional aspect of the present invention is related to a vaccine composition for inducing immune response against Leishmaniasis in mammals. In a preferred aspect, the present invention relates to use of HbR-polypeptide as marker for diagnosis of Leishmania in kala-azar patients. |
申请公布号 |
US2015306195(A1) |
申请公布日期 |
2015.10.29 |
申请号 |
US201414648538 |
申请日期 |
2014.04.11 |
申请人 |
NATIONAL INSTITUTE OF IMMUNOLOGY ;INDIAN INSTITUTE FO CHEMICAL BIOLOGY |
发明人 |
MUKHOPADHYAY Amitabha;ROY Syamal;GUPTA Deepika;GUHA Rajan;RASTOGI Ruchir |
分类号 |
A61K39/008;G01N33/569;C07K14/44 |
主分类号 |
A61K39/008 |
代理机构 |
|
代理人 |
|
主权项 |
1. A HbR-DNA for inducing sterile protection against virulent Leishmania, wherein said DNA comprises nucleotide sequence selected from the group consisting of: a) nucleotide sequence as set forth in any one of SEQ ID NO: 1 (HbR-FL), SEQ ID NO: 2 (HbR-N) or fragments thereof; b) a nucleotide sequence that encodes polypeptide having amino acid sequence as set forth in SEQ ID NO: 3. |
地址 |
New Delhi IN |